Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes.

Zhang Y, Schroeder BE, Jerevall PL, Ly A, Nolan H, Schnabel CA, Sgroi DC.

Clin Cancer Res. 2017 Dec 1;23(23):7217-7224. doi: 10.1158/1078-0432.CCR-17-1688. Epub 2017 Sep 22.


Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast Cancer.

Sestak I, Zhang Y, Schroeder BE, Schnabel CA, Dowsett M, Cuzick J, Sgroi D.

Clin Cancer Res. 2016 Oct 15;22(20):5043-5048. Epub 2016 Jun 1.


Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.

Brachtel EF, Operaña TN, Sullivan PS, Kerr SE, Cherkis KA, Schroeder BE, Dry SM, Schnabel CA.

Oncotarget. 2016 May 10;7(19):27220-31. doi: 10.18632/oncotarget.8449.


Molecular testing as a tool for the management of metastatic cancer patients.

Cherkis KA, Schroeder BE.

MLO Med Lab Obs. 2014 Mar;46(3):8-10; quiz 11. Review. No abstract available.


Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer.

Bentley TG, Schroeder BE, Schnabel CA, Erlander MG, Hsiao WC, Ortendahl JD, Broder MS.

J Med Econ. 2014 Aug;17(8):527-37. doi: 10.3111/13696998.2014.909817. Epub 2014 May 14.


Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence.

Zhang Y, Schnabel CA, Schroeder BE, Jerevall PL, Jankowitz RC, Fornander T, Stål O, Brufsky AM, Sgroi D, Erlander MG.

Clin Cancer Res. 2013 Aug 1;19(15):4196-205. doi: 10.1158/1078-0432.CCR-13-0804. Epub 2013 Jun 11.


Development and validation of a 32-gene prognostic index for prostate cancer progression.

Wu CL, Schroeder BE, Ma XJ, Cutie CJ, Wu S, Salunga R, Zhang Y, Kattan MW, Schnabel CA, Erlander MG, McDougal WS.

Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6121-6. doi: 10.1073/pnas.1215870110. Epub 2013 Mar 26.


Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors.

Weiss LM, Chu P, Schroeder BE, Singh V, Zhang Y, Erlander MG, Schnabel CA.

J Mol Diagn. 2013 Mar;15(2):263-9. doi: 10.1016/j.jmoldx.2012.10.001. Epub 2012 Dec 31.


Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease.

Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH.

Nat Med. 2009 Mar;15(3):331-7. doi: 10.1038/nm.1912. Epub 2009 Feb 8.


Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.

Smith SR, Blundell JE, Burns C, Ellero C, Schroeder BE, Kesty NC, Chen KS, Halseth AE, Lush CW, Weyer C.

Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E620-7. Epub 2007 May 15.


Pramlintide acetate in the treatment of Type 2 and Type 1 diabetes mellitus.

Edelman SV, Schroeder BE, Frias JP.

Expert Rev Endocrinol Metab. 2007 Jan;2(1):9-18. doi: 10.1586/17446651.2.1.9.


Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP.

Saganich MJ, Schroeder BE, Galvan V, Bredesen DE, Koo EH, Heinemann SF.

J Neurosci. 2006 Dec 27;26(52):13428-36.


To think or not to think: synaptic activity and Abeta release.

Schroeder BE, Koo EH.

Neuron. 2005 Dec 22;48(6):873-5. Review.


Conditioned Fos expression following morphine-paired contextual cue exposure is environment specific.

Schroeder BE, Kelley AE.

Behav Neurosci. 2002 Aug;116(4):727-32.


Morphine-associated environmental cues elicit conditioned gene expression.

Schroeder BE, Holahan MR, Landry CF, Kelley AE.

Synapse. 2000 Aug;37(2):146-58.


Supplemental Content

Loading ...
Support Center